Starbucks is partnering with Ariana Grande on its latest coffee offering. The coffee chain and singer both posted twin cloud emoji tweets on Monday. Grande tagged @Starbucks, leading fans online to piece together that she was teasing the new "Cloud Macchiato," which Starbucks ($SBUX) officially launched this week. She followed those up with a pair of new tweets Tuesday morning showing the singer decked out in a Starbucks apron sipping on one of the new bevvies.
Internal documents showed that Grande was helping the company launch the new beverage, according to Business Insider.
Grande might already be considered an unofficial brand ambassador given how many times she's been snapped holding a Starbucks drink. Starbucks has not confirmed that it has a partnership with the "Thank U, Next" singer, though BI reported that as part of the promotion some stores will also feature Grande-approved playlists and songs.
The Cloud Macchiato is a twist on an Italian coffee staple. The "macchiato," literally translated to "stained" is a shot of espresso with a bit (stain) of frothed milk. Starbucks gained success bastardizing that and other Italian cafe classics with iced versions, caramel drizzles, and mocha. The Cloud version will come in cinnamon or caramel versions with a dollop of whipped cold milk foam, according to the press release.
Jay Hatfield, chief investment officer for ICAP, joined Cheddar News to discuss how markets are reacting to labor market news and what the Federal Reserve will do next in terms of interest rates.
Kristin Cavallari, who first gained fame as a cast member of the MTV reality show Laguna Beach, is now the founder of a beauty company called Uncommon James. Cheddar News anchor Hena Doba took a walk with Cavallari to discuss her many business ventures.
Heardle, the name-that-tune game inspired by the Wordle craze, is being dropped by Spotify less than a year after the music-streaming giant acquired it.
Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Keytruda on its own, according to researchers.
